Clinical trial
Case-control Study of Antiviral Therapy During Entire and the Third Trimester of Pregnancy in Preventing MTCT of HBV in Mothers With High Serum HBV DNA Load
NCT02253485 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Case-control Study of Antiviral Therapy During Entire and the Third Trimester of Pregnancy in Preventing MTCT of HBV in Mothers With High Serum HBV DNA Load
- Lead sponsor
- Beijing Ditan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2012
- Completion date
- December 31, 2015
- Enrollment
- 600 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
immune globulin, prophylaxis, telbuvidine, vaccine